+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Use of DNA purification kits for polymerase chain reaction testing of Gen-Probe Chlamydia trachomatis PACE 2 specimens



Use of DNA purification kits for polymerase chain reaction testing of Gen-Probe Chlamydia trachomatis PACE 2 specimens



Sexually Transmitted Diseases 25(5): 265-271



Background and Objectives: Confirmation testing using nucleic acid amplification has been shown to improve the sensitivity and specificity of screening tests for Chlamydia trachomatis. However, no critical information on the use of these techniques as an adjunct to Gen-Probe hybridization testing, one of the most common screening methods, has been reported to date. We examined the Roche AMPLICOR PCR C. trachomatis Test (Roche Diagnostic Systems, Branchburg, NJ) as a confirmatory test for the Gen-Probe PACE 2 C. trachomatis Test (San Diego, CA). Further, to mitigate the possible effect of interfering compounds in the Gen-Probe PACE 2 transport medium, we tested various DNA purification techniques. Study Design: C. trachomatis elementary bodies were used to spike PACE 2 Transport medium, which was serially diluted, then tested by polymerase chain reaction (PCR). Six parallel dilution series were conducted: (1) saline dilutions tested by the Syva Direct Specimen Test, (2) Roche AMPLICOR transport medium dilutions tested by PCR, and (3-6) dilutions in PACE 2 transport medium purified respectively by GENECLEAN 11 (BIO101, Vista, CA), Puregene (Gentra Systems, Inc., Research Triangle Park, NC), Microcon 100 (Amicon, Inc., Beverly, MA) DNA isolation kits, and no DNA purification, all tested by PCR. The system giving the best results by in vitro endpoint dilution trials was then used to confirm human specimens previously tested by the Gen-Probe method. Results: PCR detected C. trachomatis at 11 twofold dilutions greater than PACE 2 and equivalent to detection of a single elementary body by Syva Direct Specimen Test. DNA purification of spiked PACE 2 transport medium by the Microcon 100 kit produced the most consistent PCR detection endpoints, equivalent to endpoints of spiked AMPLICOR transport medium. Endpoints with no DNA purification step were variable and lower. Of 78 endocervical specimens negative by PACE 2 and Gen-Probe Probe Competition Assay, 12 (15.3%) were positive by Microcon DNA purification/PCR testing. Conclusions: PCR can be used as confirmation method for Gen-Probe PACE 2 testing, but testing must be performed with a DNA purification procedure.

(PDF emailed within 0-6 h: $19.90)

Accession: 009702441

Download citation: RISBibTeXText

PMID: 9587179

DOI: 10.1097/00007435-199805000-00009


Related references

Confirmation of Gen-Probe PACE 2 Chlamydia trachomatis nucleic acid hybridization testing by polymerase chain reaction. Abstracts of the General Meeting of the American Society for Microbiology 97(0): 189, 1997

Detection of Chlamydia trachomatis in sperm by the polymerase chain reaction and Gen-Probe Pace 2 nuclear probe. Archives of Gynecology & Obstetrics 255(SUPPL ): S464, 1994

Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Molecular and Cellular Probes 11(4): 243-249, 1997

Improved sensitivity of a modified polymerase chain reaction amplified DNA probe in comparison with serial tissue culture passage for detection of Chlamydia trachomatis in conjunctival specimens from nepal. Diagnostic Microbiology and Infectious Disease 12(2): 133-137, 1989

Detection of Chlamydia trachomatis by ligase chain reaction compared with polymerase chain reaction and cell culture in urogenital specimens. Genitourinary Medicine 71(6): 382-386, 1995

Detection of Chlamydia trachomatis infection in male and female urine specimens and endocervical specimens using polymerase chain reaction. Abstracts of the General Meeting of the American Society for Microbiology 94(0): 569, 1994

Use of ligase chain reaction and polymerase chain reaction on urine specimens to detect Chlamydia trachomatis infections in a sexually transmitted diseases clinic in Singapore. Annals of the Academy of Medicine, Singapore 28(2): 245-251, 1999

Polymerase chain reaction (PCR) detection of porcine Chlamydia trachomatis and ruminant Chlamydia psittaci serovar 1 DNA in formalin-fixed intestinal specimens from swine. Journal of Veterinary Medicine Series B 44(3): 185-191, 1997

Prospective comparison of the Gen-probe PACE 2 assay and the Abbott ligase chain reaction for the direct detection of Chlamydia trachomatis in a low prevalence population. Journal of Medical Microbiology 48(5): 507-510, 1999

Detection of chlamydia trachomatis in urogenital specimens by polymerase chain reaction. Genitourinary Medicine 67(3): 211-214, 1991

Detection of Chlamydia trachomatis in endocervical specimens by polymerase chain reaction. Journal of Clinical Microbiology 30(11): 2847-2851, 1992

Detection of Chlamydia trachomatis in clinical specimens by the polymerase chain reaction. European Journal of Clinical Microbiology & Infectious Diseases 9(12): 864-868, 1990

Detection of chlamydia trachomatis in clinical specimens using the polymerase chain reaction. Proceedings of the University of Otago Medical School 67(3): 53-54, 1989

Evaluation of Gen-Probe Pace 2 Probe Competition Assay for verification of specimens positive for Chlamydia trachomatis and Neisseria gonorrhoeae. Abstracts of the General Meeting of the American Society for Microbiology 95(0): 83, 1995